Courtney A McKnight
Courtney A McKnight
Clinical Associate Professor of Epidemiology
-
Professional overview
-
Dr. Courtney McKnight is a Principal Investigator specializing in mixed methods research focused on the epidemiology of drug use, opioid overdose, HIV and HCV infection. Dr. McKnight has over 20 years of experience conducting public health research related to drug use, as well as field experience as a harm reduction service provider.
Prior to joining NYU, Dr. McKnight served as the assistant director of research at the Chemical Dependency Institute at the Icahn School of Medicine at Mount Sinai, where she was an investigator and project director on numerous federally funded research studies, including evaluations of syringe services programs; investigations of the drivers that contribute to disparate rates of HIV and HCV; and interventions to increase access to HIV and HCV testing and care.
Previous to Dr. McKnight’s work in research, she directed a harm reduction program for women who use drugs and volunteered at a syringe services program in New Jersey.
Dr. McKnight received her DrPH from the City University of New York Graduate Center, her Master of Public Health from Hunter College, and her Bachelor of Arts in sociology from Rutgers University. Her dissertation examined the impact of Medicaid coverage of methadone and buprenorphine on treatment access for opioid dependent beneficiaries.
Dr. McKnight’s current research interests include examining the shifting landscape of illicit opioids, including the increasing prevalence of illicitly manufactured fentanyl, and risk environments of people who use drugs.
-
Education
-
BA, Women's Studies, Rutgers University, New Brunswick, NJMPH, Community Health Education, Hunter College, New York, NYDrPH, The City University of New York, New York, NY
-
Areas of research and study
-
Behavioral ScienceDrug addictionEpidemiologyHarm reductionHepatitisHIV/AIDSInfectious DiseasesMixed-Methods ResearchOpioidQualitative ResearchSocial epidemiologySubstance Abuse
-
Publications
Publications
Effectiveness of respondent-driven sampling for recruiting drug users in New York City : Findings from a pilot study
Respondent-driven sampling in a study of drug users in New York City : Notes from the field
Update : Syringe exchange programs - United States, 2002
What's community got to do with it? Implementation models of syringe exchange programs
AbstractDowning, M., Riess, T. H., Vernon, K., Mulia, N., Hollinquest, M., McKnight, C. A., Des Jarlais, D. C., & Edlin, B. R. (n.d.).Publication year
2005Journal title
AIDS Education and PreventionVolume
17Issue
1Page(s)
68-78AbstractSyringe exchange programs (SEPs) have been shown to be highly effective in reducing HIV transmission among injection drug users (IDUs). Despite this evidence, SEPs have not been implemented in many communities experiencing HIV epidemics among IDUs. We interviewed 17 key informants in nine U.S. cities to identify factors and conditions that facilitated or deterred the adoption of SEPs. Cities were selected to represent diversity in size, geographic location, AIDS incidence rates, and SEP implementation. Key informants included HIV prevention providers, political leaders, community activists, substance use and AIDS researchers, and health department directors. SEPs were established by one or more of three types of implementation models: (a) broad community coalition support, (b) community activist initiative, and (c) top-down decision making by government authorities. In each model, coalition building and community consultation were critical steps for the acceptance and sustainability of SEPs. When others were not prepared to act, community activists spearheaded SEP development, taking risks in the face of opposition, but often lacked the resources to sustain their efforts. Leadership from politicians and public health officials provided needed authority, clout, and access to resources. Researchers and scientific findings lent force and legitimacy to the effort. Rather than adopting adversarial positions, successful SEP implementers worked with or avoided the opposition. Fear of repercussions and lack of leadership were the greatest barriers to implementing SEPs. Communities that successfully implemented SEPs were those with activists willing to push the agenda, public officials willing to exercise leadership, researchers able to present authoritative findings, and proponents who effectively mobilized resources and worked to build community coalitions, using persistent but nonadversarial advocacy.Public Funding of US Syringe Exchange Programs
What predicts which metropolitan areas in the USA have syringe exchanges?
Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.
As Evidence Mounts that ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies.
Fentanyl in NYC
Fentanyl Is Fueling an Unprecedented Rise in Overdose Deaths.
In New York, fentanyl replaces heroin, without the knowledge of drug addicts.
Invited Panelist for Selected Presentations at the IHRC23 Press Conference.
Large number of drug users might be unknowingly using fentanyl
Many people who use heroin are getting fentanyl with it.
More than 80% of drug users test positive for fentanyl.
Most Injection Drug Users Are Not Seeking Out Fentanyl
Most Injection Drug Users Are Not Seeking Out Fentanyl.
Most Injection Drug Users Are Not Seeking Out Fentanyl.
Most People Who Inject Drugs in NYC Test Positive for Fentanyl.
Vast Majority of Fentanyl Use is Unintentional. Reported on Spectrum News NY1
‘Tranq’: the flesh-rotting drug adding to America’s opioid crisis.